World Trade Factory™

IPO-bound cardiac stent maker Integris Medtech turns profitable in FY25, approaches capital markets for debt reduction

IPO-bound cardiac stent maker Integris Medtech turns profitable in FY25, approaches capital markets for debt reduction

Integris Medtech IPO | The company has filed preliminary papers with the SEBI for fund raising via initial public offering (IPO).

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.